The pharmaceutical giant's family trust has invested in one of Mumbai's most coveted luxury properties, acquiring a sea-view Worli residence spanning over 17,000 square feet.

Discover the top upcoming infrastructure projects in Hyderabad, including Metro Rail Phase 2, Regional Ring Road, and Pharma City. See how these developments are driving real estate growth and investment opportunities in 2025

Vibha Shanghvi, from Sun Pharma’s promoter group, has purchased two sea-facing luxury apartments in Worli’s Naman Xana for ₹130 crore, highlighting Mumbai’s booming luxury real estate market.

Microsoft India has acquired 121,000 square yards in Nandigama, Hyderabad, from Natco Pharma for ₹181.25 crore, as recorded in a Propstack sales deed, signaling its growing regional focus.

Sanofi, the Indian arm of the French pharmaceutical giant, is set to divest its Headquarters in Mumbai , a standalone building in the posh Powai locality. This building, spanning over 150,000 sq ft, currently houses the company’s country headquarters.

GV Research Platform (GVRP), a major bio-pharma contract research organisation, has leased a 130,000-square-foot Hyderabad R&D facility from Rx Propellant, a life sciences infrastructure supplier. The 10-year, Rs. 162 crore agreement is India's biggest life sciences real estate deal.

The family of BDR Pharmaceuticals' Chairman & Managing Director bought two sea-view flats in Worli for roughly ₹81 crore, marking a significant investment in Mumbai's luxury real estate market. These apartments on the 39th livable level of the ultra-luxurious Raheja Artesia building have 6,670 sq ft

IndoSpace, a developer of industrial and logistics parks, has invested Rs 1000 Cr to expand its warehouse presence in NCR